Đang chuẩn bị liên kết để tải về tài liệu:
Blood and Blood Transfusion - part 7

Dành cho người lớn hội chứng suy hô hấp sau khi tập trung thử nghiệm gamma globulin tĩnh mạch và các IgG kháng thể phản ứng đơn nhân. Lancet 1998; 352:1601-2. 14 Van Buren NL, Stronek DF, Clay ME, McCullough J, Dalmasso AP.Transfusionrelated tổn thương phổi cấp tính gây ra bởi một kháng thể bạch cầu hạt NB2 cụ thể ở một bệnh nhân với ban xuất huyết giảm tiểu cầu huyết khối | CRITICAL CARE FOCUS BLOOD AND BLOOD TRANSFUSION 13 Dooren MC Ouwehand WH Verhoeven AJ dem Borne AE Kuijpers RW. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet 1998 352 1601-2. 14 Van Buren NL Stronek DF Clay ME McCullough J Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990 30 42-5. 15 Lubenko A Brough S Garner S. The incidence of granulocyte antibodies in female blood donors results of screening by a flow cytometric technique. Platelets 1994 5 234-5. 16 Hudson LD Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest 1999 116 74S-82S. 56 6 The use of colloids in the critically ill CLAUDIO MARTIN Introduction The importance of an adequate circulating volume in the critically ill is well established. Colloids are widely used in the replacement of fluid volume although doubts remain as to their benefits. Different colloids vary in their molecular weight and therefore in the length of time they remain in the circulatory system. Because of this and their other characteristics they may differ in their safety and efficacy. Human albumin solutions are available for use in the emergency treatment of shock and other conditions where restoration of blood volume is urgent and also in patients with burns and hypoproteinaemia. Plasma albumin synthetic colloids and crystalloids may all be used for volume expansion but the first two are expensive and crystalloids have to be given in much larger volumes than colloids to achieve the same effect. Synthetic colloids provide a cheaper safe effective alternative. There are three classes of synthetic colloid dextrans gelatins and hydroxyethyl starches. Each is available in several formulations with different properties which affect their initial plasma expanding effects retention in the circulation and side-effects. This